Biologic Studies Group -COVID-19, The University of Manchester

Biologic Studies Group:This group is part of the Versus Arthritis Centre for Epidemiology and hosts a number of UK national biologic and Other new targeted drug registers. The primary aim of these studies is to investigate the long-term safety of these newer therapies. The group consists of the following studies:1. BSRBR-RA – The British Society for Rheumatology Biologics Register - Rheumatoid Arthritis2. BADBIR – The British Association of Dermatologists’ Biologic Interventions Register3. BSPAR EN - Study of Enbrel in Children with JIA4. BCRD - Arthritis Research UK Study of Biologics in Children with Rheumatic Diseases5. BILAG BR - Biologics Register Prospective Cohort Study of Lupus6. BRAGGSS - Biologics in Rheumatoid Arthritis Genetics and Genomics Study SyndicateExpertise:The main areas of expertise include the epidemiology and genetics of rheumatic disease,pharmacovigilance and pharmacoepidemiology.